Zuellig paid 2.6 billion won of royalty to head office last year.

Zuellig Pharma Korea reported the royalty payment to the head office, Zuellig Pharma Holdings. Ltd. at 2,640 million won on charge of the marketing and information services. (3,100 MW in 2004 and 2,635 MW in 2003). Zuellig Korea is a 95% stock owned company by Zuellig Pharma Holdings Ltd.

Zuellig Korea also received the service fees in 2005 for the credit collection and marketing activities...